Share on

Dietary supplements for human health. What do we really know? A systematic review of umbrella reviews

Authors

Abstract

Background and objective. The potential benefits of dietary supplements for human health have been known since ancient times, but high-quality evidence on their efficacy is lacking. Furthermore, the overwhelming amount of available studies contributes to the vagueness of this topic. The aim of this systematic review was to summarize the evidence on the health benefits of dietary supplements.
Methods. A Medline search (via PubMed) was performed.
Results. 62 umbrella reviews (also known as reviews of reviews) were retrieved. Most of the results/findings (41.3%) suggested potential beneficial effects of dietary supplements on human health, but with low to very low certainty of evidence. Twenty results/findings (26.7%) supported the efficacy of dietary supplements in improving biochemical parameters and preserving human health, with moderate to high certainty of evidence. All other studies showed uncertain/conflicting results or inefficacy.
Conclusions. The demonstration of the beneficial properties of dietary supplements is far from conclusive and high-quality studies are needed.

INTRODUCTION

Dietary supplements (or food supplements) are defined by the US Food and Drug Administration (FDA) as “vitamins, minerals, herbs or other botanicals, amino acids or other dietary substances to be used to supplement the diet” [1], and by the Directive 2002/46/EC of the European Parliament and the Council as “concentrated sources of nutrients or other substances with a nutritional or physiological effect, alone or in combination, marketed in dose form (such as capsules, pastilles, tablets, pills and other similar forms, sachets of powder, ampoules of liquids, drop dispensing bottles, and other similar forms of liquids and powders) designed to be taken in measured small unit quantities” [2-4]. Although they have only been regulated for a few decades, the potential effects of minerals, vitamins, and botanicals on human health have been known since ancient times [5]. One of the earliest documents on “phytotherapy”, known as the Egyptian “Ebers papyrus”, dates to 2900 BC and includes more than 700 plant-based health remedies, such as onion, garlic, and pomegranate [6, 7]. In 2600 BC, an additional “list” of natural products with potential benefits for human health was represented in cuneiform on clay tablets by an unknown scholar from Mesopotamia [6]. A few centuries later, the Greeks and Romans used “medicinal herbs” to treat seasonal ailments, respiratory disorders, headaches, heartburn, and a wide plethora of “minor” conditions (e.g., wounds and burns) [6, 7]. The “cult” of natural products in the Middle Ages was preserved in the monasteries of Germany, England, France, and Ireland and was gradually enriched with Chinese, American and Indian herbs by the Arabs, Marco Polo and Vasco Da Gama [6, 7]. Until the isolation of alkaloids from pomegranate, ipecacuanha, and poppy in the early 19th century, which opened the new era of “medicinal chemistry”, the use of natural products remained the only remedy for the prevention and treatment of many diseases [5, 8]. However, the advent of pharmaceutical sciences did not spell the demise of phytotherapy. In fact, many drugs currently used in clinical practice are directly isolated from plants (e.g., paclitaxel and morphine) [9], and natural products are widely used as “alternative” medicines, although their efficacy is mainly based on traditional or folk use. In recent decades, the concept of “rational phytotherapy”, based on the identification and study of specific active components from plants, has been introduced [7], but this has led to a confusing scenario. Indeed, there is an impressive number of preclinical and clinical studies evaluating the pharmacological value of plant-derived compounds, but they are very heterogeneous in terms of animals/population selected, choice of intervention, dosage, follow-up period and results. The lack of rigorous studies on the ability of vitamins and minerals to maintain, support, or optimize physiological functions also represents a limitation. These supplements can correct deficiencies and contribute to general homeostasis (e.g., vitamin C for scurvy, vitamin D and calcium for bone metabolism, vitamin K for bleeding disorders) [2, 10]. However, over-the-counter products are often used by individuals without signs and symptoms of deficiency, especially in Europe and North America, despite the lack of conclusive evidence regarding their role in supporting physiological balance in such population [10-12]. Thus, there is a kind of “boilerplate” that does not allow us to understand the role of dietary supplements in the “real world” context. The aim of this systematic review of umbrella reviews is to summarize what is known and highlight what is missing regarding the health benefits of dietary supplements, to shed light on this controversial and debated field.

MATERIALS AND METHODS

Study identification and selection

We launched the search string on Medline on June 1st, 2023. Therefore, data on studies published in 2023 are not complete. Our goal was to set up a search strategy to identify reviews of reviews (also known as umbrella reviews) investigating the effects of dietary supplements on human health. We combined search queries containing terms as “food”, “dietary”, “herbal”, “nutritional”, “nutraceutical”, “natural” as well as “supplements”, “remedies”, “substances”, “ingredients”, “dietary supplements” (and related terms), “phytotherapy” using the Boolean operators “AND” and “OR”. Filters to identify only studies conducted on humans and written in English were applied (for further detail on search strategy see Table S1 available online as Supplementary Materials).

We carried out duplicates detection and the whole screening process of titles and abstracts using the Rayyan tool [13]. The screening was independently carried out by three Authors (EP, MAM and EL).

After duplicates removal, we identified additional studies conducted on animals that had not yet been excluded by applying the previous filters. In particular, records containing terms that referred to studies not conducted on humans in the title such as “animal”, “mice”, “rat”, “murine”, “rodents”, “rodent”, “rabbit”, “piglets”, “canine”, “broiler” were removed.

Then we selected only those records containing keywords such as “meta-analysis”, “meta-analyses”, “review”, “reviews”, “systematic review” in the title. Further screening was carried out using other keywords as “umbrella review”, “overview of evidence”, “overview of reviews”, “overview of systematic reviews”, “review of reviews”, “review of evidence”, “review of meta-analyses”, “summary of evidence” and “summary of systematic reviews” to obtain the final set of studies assessed for eligibility.

Three Authors (EP, MAM and EL) checked the abstracts of potentially includible umbrella reviews and excluded those that did not fulfill the inclusion criteria.

Inclusion criteria

The inclusion criteria were formulated according to the Population, Intervention, Control, Outcome, and Study design (PICOS) framework.

Population (P): healthy subjects or patients with various types of disease, of any age group, including children, adults, or pregnant women. Umbrella reviews were also included when the population was unspecified, provided it was clear that only human studies were considered. Intervention (I): dietary supplements, regardless of dosage form and route of administration. Control (C): not required. Outcome (O): any effects on human health. Study design (S): umbrella reviews.

Exclusion criteria

We excluded articles that were not umbrella reviews, did not investigate dietary supplements, or did not directly evaluate health outcomes.

Data extraction from the umbrella reviews

For each umbrella review included, we extracted the following information, if reported: number of reviews included classified by type (i.e., systematic review, systematic review with meta-analysis, meta-analysis only); total number of primary studies included or descriptive statistics (mean and standard deviation or median and range) on the number of primary studies in each included review; study design of the primary studies; total number of patients included or descriptive statistics (as above) on the number of patients in each included review; characteristics of the population.

For each umbrella review, a summary of the main results was also provided and, if available, the level of certainty of the conclusions (high/moderate certainty, low certainty, inconclusive) was reported.

Data collection was carried out by two Authors (EP and MAM), using the spreadsheet software Microsoft Excel. Any discrepancies were discussed with a third Reviewer (EL).

RESULTS AND DISCUSSION

Identification and selection of umbrella reviews

Overall, 124,298 records were identified via Medline. After duplicates removal, 121,360 records were selected and screened. Among the 106,313 studies on humans, 7,105 reviews and meta-analyses were identified. Of them, 122 were finally assessed for eligibility. 62 umbrella reviews were included according to the defined exclusion criteria and 60 were excluded. The complete workflow leading to the inclusion of 62 studies is summarized in the flow chart (Figure 1).

The identified records were then plotted by year of publication, considering all the 121,360 non-duplicated records selected in Medline (Figure 2a).

Studies directly investigating or summarizing evidence on the effects of the consumption of different dietary supplements on human health have been published since 1945. The number of published papers per year shows little increase for some decades and then around the beginning of the last century an exponential growth starts, with the highest number registered to date during 2021 (9,174 studies).

All the 121,360 identified records were also grouped by the country of publication of the study, which is intended as the authors’ affiliation declared country. In case of affiliations belonging to different countries in one paper, each country is counted as 1. The leading publishing country is USA, followed by China and UK (Figure 2b).

Figure 3a shows the 7,015 systematic reviews and meta-analyses (including umbrella reviews) obtained during the screening process.

Studies resuming the evidence of the effects of the consumption of different dietary supplements on human health have been published since 1976.

The trend is similar to that illustrated in Figure 2a. In fact, the number of published systematic reviews is steady until the beginning of the last century, then an exponential increase is observed with the highest number of published systematic reviews to date in 2021 (1,008).

The same 7,015 records were also plotted by country of publication, which is extracted from authors’ affiliation country. As above, in case of authors’ affiliations belonging to different countries in one paper, each country is counted as 1 (Figure 3b). The leading publishing country is China, followed by USA and Iran.

The number of published umbrella reviews over the years was plotted considering only the 62 records included (Figure 4). Umbrella reviews on the effects of the consumption of different dietary supplements have been published since 2011. In particular, an increasing publishing trend seems to be observed since 2018, with the highest number reached in 2022 (21 studies).

Systematic review

Table 1 summarizes the general characteristics of the included reviews. Twenty-four (35.8%) were reviews of systematic reviews (SRs) [14-37], 19 (28.4%) were reviews of meta-analysis (MA) [38-57], 21 (31.3%) were reviews of SRs with MA [14, 15, 19, 58-75], and 3 (4.5%) were i) reviews of Mendelian randomisation studies and SRs [23], ii) reviews of MA and umbrella reviews [39], or iii) reviews of Mendelian randomisation studies and MA [45] (some umbrella reviews included more than one type of review). The number of studies on dietary supplements included in each review ranged from one to 289, and the interventions were very heterogeneous. In fact, forty-six reviews focused on the effects of vitamins [16, 17, 21, 23-25, 28, 29, 32-34, 39, 41, 44-46, 49, 55, 57, 59-61, 65, 68, 71, 73], 21 of minerals [24, 28, 32, 34, 36, 39, 41, 47, 60, 67, 72], 11 of omega-3 fatty acids [17, 21, 24, 39, 42, 44, 46, 47, 52, 56, 62], 10 of prebiotics/postbiotics/synbiotics [17, 18, 26, 27, 38, 39, 46, 48, 53, 74], 10 of proteins and amino acids [15, 17, 19, 29, 35, 69], one of lipid-based nutrients [44], 28 of others interventions/supplements (e.g., curcumin [30, 46, 51, 64], Camellia sinensis L. – green tea [31, 64, 66, 67], coenzyme Q10 [20, 24], unspecified antioxidants [21, 63], polyphenols [39, 54], Allium sativum L. (garlic) [31, 50]). Some reviews have focused on more than one dietary supplement.

Details on the characteristics of each study are given in Table S2 available online as Supplementary Materials. Overall, the population was highly heterogeneous, ranging from healthy to chronically ill people, with a high risk of overlap between patients and/or studies. Twenty results/findings (26.7%) supported the efficacy of dietary supplements in improving biochemical parameters (such as inflammatory biomarkers and fasting glucose) and in preserving human health (e.g., by reducing the risk of anemia, migraine and fractures), with moderate to high certainty of evidence. Most studies focused on vitamin D supplementation and demonstrated its efficacy in reducing the risk of falling in adult patients when administered in the elderly at risk of malnutrition and in the elderly with dementia (risk reduction ranging from 14.0% to 19.0%) [68]. Furthermore, vitamin D supplementation (8-24 weeks) has been associated with a slight, but not significant, reduction in insulin resistance (standardized mean difference, SMD, compared with placebo [95% confidence interval, CI]: -0.25 [-0.53, 0.04] for the homeostatic model assessment index – HOMA index) [46]. In this regard, other dietary supplements could improve glucose, lipid and adipose tissue metabolism. For example, curcumin supplementation (6-12 weeks) reduced fasting glucose levels in women with polycystic ovarian syndrome (SMD compared with placebo: -3.31 [-4.89, -1.79]) [46], as well as blood lipid levels in the general population (total cholesterol, TC: -25.13 mg/dl [40.6, -9.28]; low-density lipoprotein cholesterol, LDL-C: -39.83 [75.02, 4.25] after 8-12 weeks, compared with placebo) [64]. Vegetable oils, phytosterols, plant proteins and Camellia sinensis L. exhibited lipid-lowering levels (vegetable oils, 2-104 weeks: -6.7 to -19.0 mg/dl for TC and -0.4 to -16.2 mg/dl for LDL-C; phytosterols, 3-85 weeks: -7.7 to -16.4 mg/dl for TC and -10.4 to -23.7 mg/dl for LDL-C; plant proteins, 3-208 weeks: -6.4 to -23.2 mg/dl for TC and -4.76 to -21.7 mg/dl for LDL-C; Camellia sinensis L., 2-96 weeks: -0.4 to -27.6 mg/dl for TC and -0.2 to -24.8 mg/dl for LDL-C) [64], while probiotics (8-12 weeks) decreased fasting blood glucose in adult patients (SMD compared with placebo: -4.70 [-8.43, -0.97]) [46]. Also, probiotics reduced body mass index (BMI) and waist circumference in obese people, particularly after 8 weeks of supplementation (SMD for BMI from baseline: -0.11 [-0.40, 0.18] for periods <8 weeks vs -0.21 [-0.32, -0.09] for 8-12 weeks; SMD for body weight from baseline: -0.25 [-0.80, 0.30] for periods ≤8 weeks vs -0.41 [-0.61, -0.20] for more than 8 weeks) [48].

Many reviews have focused on the effects of dietary supplements in pregnant women showing, for example, a positive association between vitamin D use and reduced risk of preterm delivery (risk ratio, RR: 0.36 [0.14, 0.93]) or low birth weight (RR: 0.40 [0.24, 0.67]) [25]. High magnesium intake [72] and omega-3 supplementation [62] decreased the intensity/frequency of migraine in pregnant women and the risk of pre-eclampsia (RR: 0.75 [0.57, 0.98]) and low-birth weight (RR: 0.72 [0.55, 0.94]), respectively. Finally, vitamin A increased retinol concentrations in maternal serum and breast milk and reduced the risk of anemia and maternal clinical infection in women of reproductive age [32].

Consistent results have been found regarding the anti-inflammatory effects of dietary supplements. For instance, C-reactive protein (CRP) levels were significantly reduced by vitamin C, zinc and melatonin supplementation, while tumor necrosis factor (TNF) and interleukin (IL)-6 levels were significantly lowered by melatonin supplementation. The effects of vitamin D on inflammatory markers, however, were controversial [60, 65]. Omega-3 supplementation has also shown significant effects on CRP, TNF and IL-6 levels [42]. However, beneficial effects on inflammatory biomarkers do not necessarily imply clinical efficacy in the prevention and treatment of inflammatory diseases. For instance, the double-blind, randomized, placebo-controlled ASCEND-Eye trial showed no significant benefit for omega-3 fatty acids on diabetic retinopathy [76]. Furthermore, Cochrane reviews have shown that omega-3 intake has little or no effect in preventing cardiovascular events [77], as well as dry eye symptoms in patients with dry eye disease [78].

Thirty-one results/findings (41.3%) suggested potential beneficial effects of dietary supplements on human health, but with a low to very low certainty of evidence. Although these reviews yielded promising results on the health effects of dietary supplements, some doubts remain on the methodological quality of the included studies. Finally, eight results/findings (10.7%) were uncertain/conflicting, thirteen (17.3%) suggested that dietary supplements are ineffective (certainty of evidence low to very low), and only three (4.0%) concluded that dietary supplements have no beneficial effects on human health (certainty of evidence moderate to high). In this regard, vitamin D supplementation (without calcium) did not prevent preterm birth, stillbirth and cesarean section in pregnant women [16], nor hip fracture or any other fractures in healthy individuals [25]. Furthermore, calcium supplementation had no effect on body weight and BMI in women of reproductive age [32].

CONCLUSIONS

The demonstration of the beneficial properties of dietary supplements is far from conclusive and further high-quality studies are needed to confirm the potential benefits of vitamins, minerals and botanicals in the prevention of diseases or their recurrence, with affordable costs justifying their use. In fact, in most papers the quality of the evidence was low or uncertain or even inconclusive, and the studies showed an effect mainly on biomarkers or soft endpoints. In our opinion, a more regulated process (e.g., through randomized controlled trials), simpler but somehow similar to that of drugs or substance based medical devices, is needed for dietary supplements to clearly demonstrate their benefits and justify the additional costs to patients and the community.

LIMITATIONS

This is a review of umbrella reviews, which increases the risk of missing relevant data not extracted in the original umbrella reviews or in the primary studies they included. Additionally, the selected reviews differ substantially in terms of the type and number of included studies, resulting in the variability of sample size and types of interventions considered. There is also a high risk of overlap between patient populations, potentially leading to an overestimation of the effect. In fact, several umbrella reviews on the same topic may have included the same primary studies and, consequently, the same patient data. This may have artificially increased the statistical power of the result without additional evidence or new data.

Other Information

Authors’ contributions

Conceptualization: AM, EL; methodology: EP, MAM, EL; software: EP, MAM, EL; investigation: EP, MAM, EL; data curation: EP, MAM, EL; writing – original draft preparation: EP, MAM; writing – review and editing: EP, MAM, VC, SDM, CG, AM, EL; supervision: AM, EL.

Conflict of interest statement

The Authors declare no conflict of interest.

Address for correspondence: Ersilia Lucenteforte, Dipartimento di Statistica, Informatica, Applicazioni “G. Parenti”, Università degli Studi di Firenze, Viale Morgagni 59, 50134 Florence, Italy. E-mail: ersilia.lucenteforte@unifi.it.

*These Authors contributed equally to this work

Figures and tables

Figure 1. Flow chart of search.

Figure 2. a) Number of non-duplicated records identified on Medline, by year of publication; b) number of non-duplicated records identified on Medline ranked by the best 10 countries of publication.

Figure 3. a) Number of non-duplicated systematic reviews and meta-analyses identified on Medline, by year of publication; b) number of non-duplicated systematic reviews and meta-analyses identified on Medline ranked by the best 10 countries of publication.

Figure 4. Number of published umbrella reviews investigating the effects of dietary supplements on human health outcomes by year of publication.

Type of the umbrella reviews, n (%)*; median number of the included studies [range]
Reviews of SRsReviews of MAReviews of SRs with MAOthers** 24 (35.8%); 15 [5-87]19 (28.4%); 30 [1-195]21 (31.3%); 12 [4-141]3 (4.5%); 74 [13-289]
Main findings, n (%)***
Efficacy with low certainty/insufficient evidence or without information on the quality of evidenceEfficacyInefficacy with low certainty/insufficient evidence or without information on the quality of evidenceInconclusive/conflicting resultsInefficacy 31 (41.3%)20 (26.7%)13 (17.3%)8 (10.7%)3 (4.0%)
Intervention/supplements, n (%)
Vitamins    Vitamin D    Vitamin C    Vitamin D + calcium    Vitamin B9 (folic acid)    Vitamin A    β-carotene (precursor of vitamin A)    Vitamin E    Vitamin B complex    Vitamin B3 (niacin)    Vitamin B6    Vitamin B7 (inositol)    Vitamin B12    Vitamin K 46 (74.2%)20643322111111
Minerals    Zinc    Iron    Iron + vitamin B9 (folic acid)    Calcium    Selenium    Chromium    Magnesium    Iodine    Zinc + iron 21 (33.9%)333432111
Omega-3 fatty acids 11 (17.7%)
Prebiotics/probiotics/synbiotics 10 (16.1%)
Proteins and amino acids    β-hydroxy-β-methyl butyrate (leucine metabolite)    Glutamine    Tryptophan    Leucine    Not specified 10 (16.1%)21115
Lipid-based nutrients 1 (1.6%)
Others    Curcumin    Camellia sinensis L. (green tea)    Coenzyme Q10    Antioxidants (unspecified)    Polyphenols    Allium sativum L. (garlic)    Phytosterols, Serenoa repens, β-sitosterol, Pygeum africannum Hook f. and Cernilton (rye grass pollen)®    Pollen    Spicy foods and chili pepper    Caffeine    Zingiber officinale Roscoe (ginger), Hibiscus sabdariffa L., Aloe vera spp., Nigella sativa L., or Arthrospira platensis (spirulina)    Cannabis sativa spp. and Rosa canina L.     Cinnamomum verum Presl (cinnamon)    Fish oil     Vegetable oil    Guar gum, chromium picolinate, Ephedra spp. and ephedrine, Citrus aurantium L., conjugated linoleic acid, calcium, glucomannan, chitosan, Camellia sinensis L. (green tea)    Sodium bircarbonate 28 (45.2%)44222221111111111
MA: meta-analysis; SRs: systematic reviews; *some umbrella reviews included more than one type of review; **reviews of MA and umbrella reviews (n=1), Mendelian randomisation studies and SRs (n=1), Mendelian randomisation studies and MA (n=1); ***some studies on more than one dietary supplement have reported more than one result.
Table 1. Summary of the included studies

References

  1. Young A, Bass I. The dietary supplement health and education act. Food Drug Law J. 1995;50(2):285-92.
  2. Lentjes M. The balance between food and dietary supplements in the general population. Proc Nutr Soc. 2019;78(1):97-109.
  3. Papatesta E, Kanellou A, Peppa E, Trichopoulou A. Is dietary (food) supplement intake reported in European National Nutrition Surveys?. Nutrients. 2023;15(24).
  4. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union L 183. 2002;.
  5. Dzobo K. The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. Comprehensive Pharmac. 2022;:408-22.
  6. Dias D, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2(2):303-36.
  7. Petrovska B. Historical review of medicinal plants’ usage. Pharmacogn Rev. 2012;6(11):1-5.
  8. Cragg G, Newman D. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670-95.
  9. Patridge E, Gareiss P, Kinch M, Hoyer D. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2016;21(2):204-7.
  10. Zhang F, Barr S, McNulty H, Li D, Blumberg J. Health effects of vitamin and mineral supplements. BMJ. 2020;369.
  11. Blumberg J, Bailey R, Sesso H, Ulrich C. The evolving role of multivitamin/multimineral supplement use among adults in the age of personalized nutrition. Nutrients. 2018;10(2).
  12. Wierzejska R. Dietary supplements for whom? The current state of knowledge about the health effects of selected supplement use. Int J Environ Res Public Health. 2021;18(17).
  13. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1).
  14. Antonelli M, Donelli D, Firenzuoli F. Therapeutic efficacy of orally administered pollen for nonallergic diseases: An umbrella review. Phytother Res. 2019;33(11):2938-47.
  15. Apostolopoulou A, Haidich A, Kofina K, Manzanares W, Bouras E, Tsaousi G, Stoppe C, Dardavessis T, Chourdakis M. Effects of glutamine supplementation on critically ill patients: Focus on efficacy and safety. An overview of systematic reviews. Nutrition. 2020;78.
  16. Bialy L, Fenton T, Shulhan-Kilroy J, Johnson D, McNeil D, Hartling L. Vitamin D supplementation to improve pregnancy and perinatal outcomes: An overview of 42 systematic reviews. BMJ Open. 2020;10(1).
  17. Burrows T, Teasdale S, Rocks T, Whatnall M, Schindlmayr J, Plain J, Latimer G, Roberton M, Harris D, Forsyth A. Effectiveness of dietary interventions in mental health treatment: A rapid review of reviews. Nutr Diet. 2022;79(3):279-90.
  18. Ellwood J, Draper-Rodi J, Carnes D. Comparison of common interventions for the treatment of infantile colic: A systematic review of reviews and guidelines. BMJ Open. 2020;10(2).
  19. Gielen E, Beckwee D, Delaere A, De Breucker S, Vandewoude M, Bautmans I. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: An umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121-47.
  20. Jafari M, Mousavi S, Asgharzadeh A, Yazdani N. Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian Heart J. 2018;70:S111-7.
  21. Khan S, Khan M, Riaz H, Valavoor S, Zhao D, Vaughan L, Okunrintemi V, Riaz I, Khan M, Kaluski E, Murad M, Blaha M, Guallar E, Michos E. Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: An umbrella review and evidence map. Ann Intern Med. 2019;171(3):190-8.
  22. Kim T, Lim H, Kim M, Lee M. Dietary supplements for benign prostatic hyperplasia: An overview of systematic reviews. Maturitas. 2012;73(3):180-5.
  23. Maretzke F, Bechthold A, Egert S, Ernst J, Melo van Lent D, Pilz S, Reichrath J, Stangl G, Stehle P, Volkert D, Wagner M, Waizenegger J, Zittermann A, Linseisen J. Role of vitamin D in preventing and treating selected extraskeletal diseases: An umbrella review. Nutrients. 2020;12(4).
  24. Martin Ruiz E, Olry de Labry A, Epstein D. Primary prevention of cardiovascular disease: An umbrella review. An Sist Sanit Navar. 2018;41(3):355-69.
  25. Mateussi M, Latorraca C, Daou J, Martimbianco A, Riera R, Pacheco R, Pachito D. What do Cochrane systematic reviews say about interventions for vitamin D supplementation?. Sao Paulo Med J. 2017;135(5):497-50.
  26. McKenzie Y, Thompson J, Gulia P, Lomer M. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016;29(5):576-92.
  27. Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz B, Huybrechts I. Human microbiome and metabolic health: An overview of systematic reviews. Obes Rev. 2022;23(4).
  28. Moorthy D, Merrill R, Namaste S, Iannotti L. The impact of nutrition-specific and nutrition-sensitive interventions on hemoglobin concentrations and anemia: A meta-review of systematic reviews. Adv Nutr. 2020;11(6):1631-45.
  29. Neil-Sztramko S, Teggart K, Moore C, Sherifali D, Fitzpatrick-Lewis D, Coletta G, Phillips S, Newbold K, Alvarez E, Kuspinar A, Kennedy C, Santaguida P, Ganann R. Community-based group physical activity and/or nutrition interventions to promote mobility in older adults: An umbrella review. BMC Geriatr. 2022;22(1).
  30. Pagano E, Romano B, Izzo A, Borrelli F. The clinical efficacy of curcumin-containing nutraceuticals: An overview of systematic reviews. Pharmacol Res. 2018;134:79-91.
  31. Posadzki P, AlBedah A, Khalil M, AlQaed M. Complementary and alternative medicine for lowering blood lipid levels: A systematic review of systematic reviews. Complement Ther Med. 2016;29:141-51.
  32. Rajwar E, Parsekar S, Venkatesh B, Sharma Z. Effect of vitamin A, calcium and vitamin D fortification and supplementation on nutritional status of women: An overview of systematic reviews. Syst Rev. 2020;9(1).
  33. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis J. Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348.
  34. von Salmuth V, Brennan E, Kerac M, McGrath M, Frison S, Lelijveld N. Maternal-focused interventions to improve infant growth and nutritional status in low-middle income countries: A systematic review of reviews. PLoS One. 2021;16(8).
  35. Phillips S, Lau K, D’Souza A, Nunes E. An umbrella review of systematic reviews of beta-hydroxy-beta-methyl butyrate supplementation in ageing and clinical practice. J Cachexia Sarcopenia Muscle. 2022;13(5):2265-75.
  36. Sans S, Bobo G, Zudaire L, Lafarga T, Sabate J, Casals J, Simo J. Nutritional values of raw and cooked “calcots” (Allium cepa L. resprouts), an expanding crop. J Sci Food Agric. 2019;99(11):4985-92.
  37. Grgic J, Grgic I, Pickering C, Schoenfeld B, Bishop D, Pedisic Z. Wake up and smell the coffee: caffeine supplementation and exercise performance - an umbrella review of 21 published meta-analyses. Br J Sports Med. 2020;54(11):681-8.
  38. Chang C, Yuan X, Zhang X, Chen X, Li K. Gastrointestinal microbiome and multiple health outcomes: Umbrella review. Nutrients. 2022;14(18).
  39. Fong C, Alesi S, Mousa A, Moran L, Deed G, Grant S, Tapia K, Ee C. Efficacy and safety of nutrient supplements for glycaemic control and insulin resistance in type 2 diabetes: An umbrella review and hierarchical evidence synthesis. Nutrients. 2022;14(11).
  40. Hoang T, Kim J. Phytonutrient supplements and metabolic biomarkers of cardiovascular disease: An umbrella review of meta-analyses of clinical trials. Phytother Res. 2021;35(8):4171-82.
  41. Iqbal S, Ekmekcioglu C. Maternal and neonatal outcomes related to iron supplementation or iron status: A summary of meta-analyses. J Matern Fetal Neonatal Med. 2019;32(9):1528-40.
  42. Kavyani Z, Musazadeh V, Fathi S, Hossein Faghfouri A, Dehghan P, Sarmadi B. Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. Int Immunopharmacol. 2022;111.
  43. Keramati M, Musazadeh V, Malekahmadi M, Jamilian P, Jamilian P, Ghoreishi Z, Zarezadeh M, Ostadrahimi A. Cinnamon, an effective anti-obesity agent: Evidence from an umbrella meta-analysis. J Food Biochem. 2022;46(8).
  44. Kinshella M, Omar S, Scherbinsky K, Vidler M, Magee L, von Dadelszen P, Moore S, Elango R. Effects of maternal nutritional supplements and dietary interventions on placental complications: An umbrella review, meta-analysis and evidence map. Nutrients. 2021;13(2).
  45. Liu D, Meng X, Tian Q, Cao W, Fan X, Wu L, Song M, Meng Q, Wang W, Wang Y. Vitamin D and multiple health outcomes: An umbrella review of observational studies, randomized controlled trials, and mendelian randomization studies. Adv Nutr. 2022;13(4):1044-62.
  46. Moslehi N, Zeraattalab-Motlagh S, Rahimi Sakak F, Shab-Bidar S, Tehrani F, Mirmiran P. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: An umbrella review of meta-analyses of randomized controlled trials. Nutr Rev. 2023;81(5):555-77.
  47. Motrico E, Bina R, Kassianos A, Le H, Mateus V, Oztekin D, Rodriguez-Munoz M, Moreno-Peral P, Conejo-Ceron S. Effectiveness of interventions to prevent perinatal depression: An umbrella review of systematic reviews and meta-analysis. Gen Hosp Psychiatry. 2023;82:47-61.
  48. Musazadeh V, Zarezadeh M, Ghalichi F, Ahrabi S, Jamilian P, Jamilian P, Ghoreishi Z. Anti-obesity properties of probiotics; a considerable medical nutrition intervention: Findings from an umbrella meta-analysis. Eur J Pharmacol. 2022;928.
  49. Musazadeh V, Keramati M, Ghalichi F, Kavyani Z, Ghoreishi Z, Alras K, Albadawi N, Salem A, Albadawi M, Salem R, Abu-Zaid A, Zarezadeh M, Mekary R. Vitamin D protects against depression: Evidence from an umbrella meta-analysis on interventional and observational meta-analyses. Pharmacol Res. 2023;187.
  50. Schwingshackl L, Missbach B, Hoffmann G. An umbrella review of garlic intake and risk of cardiovascular disease. Phytomedicine. 2016;23(11):1127-33.
  51. Unhapipatpong C, Polruang N, Shantavasinkul P, Julanon N, Numthavaj P, Thakkinstian A. The effect of curcumin supplementation on weight loss and anthropometric indices: An umbrella review and updated meta-analyses of randomized controlled trials. Am J Clin Nutr. 2023;117(5):1005-16.
  52. Vesco A, Lehmann J, Gracious B, Arnold L, Young A, Fristad M. Omega-3 supplementation for psychotic mania and comorbid anxiety in children. J Child Adolesc Psychopharmacol. 2015;25(7):526-34.
  53. Zarezadeh M, Musazadeh V, Ghalichi F, Kavyani Z, Nasernia R, Parang M, Jamilian P, Jamilian P, Fakhr L, Ostadrahimi A, Mekary R. Effects of probiotics supplementation on blood pressure: An umbrella meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2023;33(2):275-86.
  54. Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S. The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials. Am J Clin Nutr. 2021;114(5):1675-85.
  55. Chakhtoura M, Bacha D, Gharios C, Ajjour S, Assaad M, Jabbour Y, Kahale F, Bassatne A, Antoun S, Akl E, Bouillon R, Lips P, Ebeling P, El-Hajj Fuleihan G. Vitamin D supplementation and fractures in adults: A systematic umbrella review of meta-analyses of controlled trials. J Clin Endocrinol Metab. 2022;107(3):882-98.
  56. Choi H, Kim J, Lee K, Kim J, Lee J, Choi E, Seong H, Kim G, Park H, Jung E, Hong S, Kronbichler A, Eisenhut M, Koyanagi A, Jacob L, Yon D, Lee S, Kim M, Kostev K, Shin J, Yang J, Smith L. Omega-3 fatty acids supplementation on major cardiovascular outcomes: An umbrella review of meta-analyses of observational studies and randomized controlled trials. Eur Rev Med Pharmacol Sci. 2021;25(4):2079-92.
  57. Ganmaa D, Enkhmaa D, Nasantogtokh E, Sukhbaatar S, Tumur-Ochir K, Manson J. Vitamin D, respiratory infections, and chronic disease: Review of meta-analyses and randomized clinical trials. J Intern Med. 2022;291(2):141-64.
  58. Ao Z, Huang Z, Liu H. Spicy food and chili peppers and multiple health outcomes: Umbrella review. Mol Nutr Food Res. 2022;66(23).
  59. Ashor A, Brown R, Keenan P, Willis N, Siervo M, Mathers J. Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: An umbrella review of systematic reviews and meta-analyses. Nutr Res. 2019;61:1-12.
  60. Corrao S, Mallaci Bocchio R, Lo Monaco M, Natoli G, Cavezzi A, Troiani E, Argano C. Does evidence exist to blunt inflammatory response by nutraceutical supplementation during COVID-19 pandemic? An overview of systematic reviews of vitamin D, vitamin C, melatonin, and zinc. Nutrients. 2021;13(4).
  61. De Spiegeleer A, Beckwee D, Bautmans I, Petrovic M. Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: An umbrella review of systematic reviews and meta-analyses. Drugs Aging. 2018;35(8):719-34.
  62. Firouzabadi F, Shab-Bidar S, Jayedi A. The effects of omega-3 polyunsaturated fatty acids supplementation in pregnancy, lactation, and infancy: An umbrella review of meta-analyses of randomized trials. Pharmacol Res. 2022;177.
  63. Houze B, El-Khatib H, Arbour C. Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(Pt B):192-205.
  64. Adel Mehraban M, Tabatabaei-Malazy O, Rahimi R, Daniali M, Khashayar P, Larijani B. Targeting dyslipidemia by herbal medicines: A systematic review of meta-analyses. J Ethnopharmacol. 2021;280.
  65. Moslemi E, Musazadeh V, Kavyani Z, Naghsh N, Shoura S, Dehghan P. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis. Pharmacol Res. 2022;186.
  66. Neyestani T, Nikooyeh B. A comprehensive overview on the effects of green tea on anthropometric measures, blood pressure, glycemic and lipidemic status: An umbrella review and meta meta-analysis study. Nutr Metab Cardiovasc Dis. 2022;32(9):2026-40.
  67. Onakpoya I, Wider B, Pittler M, Ernst E. Food supplements for body weight reduction: A systematic review of systematic reviews. Obesity (Silver Spring). 2011;19(2):239-44.
  68. Poscia A, Milovanovic S, La Milia D, Duplaga M, Grysztar M, Landi F, Moscato U, Magnavita N, Collamati A, Ricciardi W. Effectiveness of nutritional interventions addressed to elderly persons: Umbrella systematic review with meta-analysis. Eur J Public Health. 2018;28(2):275-83.
  69. Rizzoli R, Biver E, Bonjour J, Coxam V, Goltzman D, Kanis J, Lappe J, Rejnmark L, Sahni S, Weaver C, Weiler H, Reginster J. Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation. Osteoporos Int. 2018;29(9):1933-48.
  70. Schultz T, Roupas P, Wiechula R, Krause D, Gravier S, Tuckett A, Hines S, Kitson A. Nutritional interventions for optimizing healthy body composition in older adults in the community: An umbrella review of systematic reviews. JBI Database System Rev Implement Rep. 2016;14(8):257-308.
  71. Shah K, Varna V, Sharma U, Mavalankar D. Does vitamin D supplementation reduce COVID-19 severity? A systematic review. QJM. 2022;115(10):665-72.
  72. Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, Caruso M, Notarnicola M, Reddavide R, Stubbs B, Solmi M, Maggi S, Vaona A, Firth J, Smith L, Koyanagi A, Dominguez L, Barbagallo M. Magnesium and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020;59(1):263-72.
  73. Xu K, Peng R, Zou Y, Jiang X, Sun Q, Song C. Vitamin C intake and multiple health outcomes: An umbrella review of systematic reviews and meta-analyses. Int J Food Sci Nutr. 2022;73(5):588-99.
  74. Zarezadeh M, Musazadeh V, Faghfouri A, Sarmadi B, Jamilian P, Jamilian P, Tutunchi H, Dehghan P. Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: An umbrella meta-analysis. Pharmacol Res. 2022;183.
  75. Grgic J, Grgic I, Del Coso J, Schoenfeld B, Pedisic Z. Effects of sodium bicarbonate supplementation on exercise performance: An umbrella review. J Int Soc Sports Nutr. 2021;18(1).
  76. Sammons E, Buck G, Bowman L, Stevens W, Hammami I, Parish S, Armitage J. ASCEND-Eye: Effects of omega-3 fatty acids on diabetic retinopathy. Ophthalmology. 2024;131(5):526-33.
  77. Abdelhamid A, Brown T, Brainard J, Biswas P, Thorpe G, Moore H, Deane K, Summerbell C, Worthington H, Song F, Hooper L. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3).
  78. Downie L, Ng S, Lindsley K, Akpek E. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Cochrane Database Syst Rev. 2019;112(12).
Authors

Eugenia Piragine - Dipartimento di Farmacia, Università di Pisa, Pisa, Italia

Marco Andrea Malanima - Dipartimento di Medicina Clinica e Sperimentale, Unità di Statistica Medica, Università di Pisa, Pisa, Italia.

Vincenzo Calderone - Dipartimento di Farmacia, Università di Pisa, Pisa, Italia

Salvatore De Masi - Clinical Trial Center (CTC), Azienda Ospedaliera Universitaria Careggi, Firenze, Italia

Carla Ghelardini - Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA), Sezione di Farmacologia e Tossicologia, Università degli Studi di Firenze, Firenze, Italia

Alessandro Mugelli - Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA), Sezione di Farmacologia e Tossicologia, Università degli Studi di Firenze, Firenze, Italia

Ersilia Lucenteforte - Dipartimento di Statistica, Informatica, Applicazioni “G. Parenti”, Università degli Studi di Firenze, Florence, Italy

How to Cite
Piragine, E., Malanima, M. A., Calderone, V., De Masi, S., Ghelardini, C., Mugelli, A., & Lucenteforte, E. (2025). Dietary supplements for human health. What do we really know? A systematic review of umbrella reviews . Annali dell’Istituto Superiore Di Sanità, 61(3), 163–172. https://doi.org/10.4415/ANN_25_03_02
  • Abstract viewed - 256 times
  • PDF downloaded - 61 times
  • Supplementary downloaded - 8 times